Prestige Consumer Healthcare Inc.
For the period ended Dec 31, 2024. Filed Feb 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Feb 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. OTHER INFORMATION
Rule 10b5-1 Trading Arrangements
The following is a summary of the material terms of the contracts, instructions or written plans for the purchase or sale of the Company's securities adopted orterminated by our officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) or directors during the three months ended December 31, 2024:
| Name and Position | Date | Action | Satisfies Affirmative Defense under Rule 10b5-(c) | Expiration Date | Total Ordinary Shares to be Sold |
|---|---|---|---|---|---|
| Mary Beth Fritz | December 2, 2024 | Adoption | X | June 30, 2025 | 10,713 |
| Senior Vice PresidentQuality & Regulatory Affairs | |||||
-35-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.